SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-15-133365
Filing Date
2015-04-16
Accepted
2015-04-16 16:30:54
Documents
8
Period of Report
2015-06-01
Effectiveness Date
2015-04-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A d902092ddef14a.htm DEF 14A 185875
2 GRAPHIC g902092g28b71.jpg GRAPHIC 5807
3 GRAPHIC g902092g91x03.jpg GRAPHIC 4918
4 GRAPHIC g902092pc_pg1a.jpg GRAPHIC 32539
5 GRAPHIC g902092pc_pg1b.jpg GRAPHIC 55764
6 GRAPHIC g902092pc_pg1c.jpg GRAPHIC 8610
7 GRAPHIC g902092pc_pg1d.jpg GRAPHIC 14662
8 GRAPHIC g902092pc_pg1e.jpg GRAPHIC 41522
  Complete submission text file 0001193125-15-133365.txt   413705
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36304 | Film No.: 15775676
SIC: 2834 Pharmaceutical Preparations